0000950170-24-103955.txt : 20240905
0000950170-24-103955.hdr.sgml : 20240905
20240905160002
ACCESSION NUMBER: 0000950170-24-103955
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240903
FILED AS OF DATE: 20240905
DATE AS OF CHANGE: 20240905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Warren Lucinda
CENTRAL INDEX KEY: 0002035620
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 241281317
MAIL ADDRESS:
STREET 1: C/O CUE BIOPHARMA, INC.
STREET 2: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
ownership.xml
4
X0508
4
2024-09-03
false
0001645460
Cue Biopharma, Inc.
CUE
0002035620
Warren Lucinda
C/O CUE BIOPHARMA, INC.
40 GUEST STREET
BOSTON
MA
02135
false
true
false
false
CHIEF BUSINESS OFFICER
false
Stock Option (right to buy)
0.66
2024-09-03
4
A
false
350000
0.0
A
2034-09-02
Common Stock
350000
350000
D
This stock option becomes exercisable in four equal semi-annual installments beginning on March 3, 2025.
/s/ Lucinda Warren by Colin Sandercock, attorney-in-fact
2024-09-05